Garnet Equity Capital Holdings Inc. bought a new position in Morgan Stanley (NYSE:MS) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 70,000 shares of the financial services provider’s stock, valued at approximately $3,673,000. Morgan Stanley comprises about 2.9% of Garnet Equity Capital Holdings Inc.’s investment portfolio, making the stock its 18th biggest holding.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Exane Derivatives grew its holdings in shares of Morgan Stanley by 303.9% in the 4th quarter. Exane Derivatives now owns 1,979 shares of the financial services provider’s stock worth $104,000 after purchasing an additional 1,489 shares during the last quarter. First Dallas Securities Inc. bought a new stake in shares of Morgan Stanley in the 4th quarter worth about $121,000. Invictus RG grew its holdings in shares of Morgan Stanley by 307.5% in the 3rd quarter. Invictus RG now owns 2,335 shares of the financial services provider’s stock worth $112,000 after purchasing an additional 1,762 shares during the last quarter. Rational Advisors LLC bought a new stake in shares of Morgan Stanley in the 3rd quarter worth about $116,000. Finally, Zions Bancorporation lifted its position in Morgan Stanley by 176.1% during the 3rd quarter. Zions Bancorporation now owns 2,463 shares of the financial services provider’s stock worth $119,000 after buying an additional 1,571 shares in the last quarter. 86.07% of the stock is currently owned by institutional investors and hedge funds.
Morgan Stanley (NYSE:MS) opened at $58.67 on Monday. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 2.75. Morgan Stanley has a 52-week low of $40.06 and a 52-week high of $58.79. The stock has a market cap of $105,130.00, a PE ratio of 16.25, a price-to-earnings-growth ratio of 1.01 and a beta of 1.49.
The firm also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Wednesday, January 31st were given a dividend of $0.25 per share. The ex-dividend date was Tuesday, January 30th. This represents a $1.00 dividend on an annualized basis and a yield of 1.70%. Morgan Stanley’s payout ratio is presently 27.70%.
In other Morgan Stanley news, CFO Jonathan Pruzan sold 52,204 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $55.35, for a total transaction of $2,889,491.40. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Chairman James P. Gorman sold 100,000 shares of the company’s stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $55.34, for a total transaction of $5,534,000.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 239,254 shares of company stock worth $13,085,019. Corporate insiders own 0.24% of the company’s stock.
Several research analysts recently issued reports on MS shares. Keefe, Bruyette & Woods upgraded shares of Morgan Stanley from a “market perform” rating to an “outperform” rating and set a $59.00 price target on the stock in a research report on Tuesday, December 12th. Zacks Investment Research upgraded shares of Morgan Stanley from a “hold” rating to a “buy” rating and set a $59.00 price target on the stock in a research report on Wednesday, January 3rd. Barclays upped their price target on shares of Morgan Stanley from $52.00 to $62.00 and gave the stock an “equal weight” rating in a research report on Tuesday, January 2nd. Societe Generale downgraded shares of Morgan Stanley from a “buy” rating to a “hold” rating in a research report on Tuesday, January 9th. Finally, Vining Sparks reiterated a “buy” rating and set a $60.00 price target on shares of Morgan Stanley in a research report on Monday, January 8th. One analyst has rated the stock with a sell rating, seven have issued a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $54.07.
About Morgan Stanley
Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.